Title: Advances in screening for pancreatic cancer susceptibility genes

click here to register

 

Speaker -
Dr. Kasmintan Schrader MBBS, FRCPC, PhD, DABMG
Medical Geneticist and co-Medical Director, Hereditary Cancer Program



 

Learning objectives: 

At the end of the session, participants will be able to:

  • Understand the burden of germline cancer susceptibility variants in pancreatic cancer
  • Consider the hereditary cancer syndromes associated with pancreatic cancer
  • Consider genetic testing approaches used by a provincial hereditary cancer service

 

Biography

Dr. Kasmintan Schrader received her medical degree from the University of Melbourne, and completed her residency in Medical Genetics and PhD in Pathology and Laboratory Medicine at the University of British Columbia. Her PhD work evolved to use next-generation sequencing to identify Mendelian disease genes. She was subsequently awarded a Canadian Institutes of Health Research Clinician-Scientist Training Award to pursue her interests in cancer susceptibility gene discovery at Memorial Sloan Kettering in New York. Dr. Schrader returned to British Columbia in 2014 to build the Familial Pancreatic Cancer Program and in 2016, became co-Medical Director of BC Cancer's Hereditary Cancer Program. Dr. Schrader researches the molecular detection of known and novel cancer predisposition genes and investigates the utility of germline variation in overall cancer care and prevention; in order to harness precision oncology for the benefit of patients and families.

Save the Dates!

Leading Strand  - Friday, December 17 at 12:30 PM ET - REGISTER

TeleGraf - Friday, December 17 at 11:00 AM ET - REGISTER 

46th Annual Scientific Meeting - June 6-9, 2022 - Presented Virtually